Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer?
- PMID: 17709796
- DOI: 10.1200/JCO.2007.11.6582
Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer?
Comment in
-
Pharmacoeconomic benefits of capecitabine-based chemotherapy in metastatic colorectal cancer.J Clin Oncol. 2008 May 1;26(13):2224-6; author reply 2228. doi: 10.1200/JCO.2008.16.2826. J Clin Oncol. 2008. PMID: 18445854 No abstract available.
-
Re: Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer?J Clin Oncol. 2008 May 1;26(13):2226-7; author reply 2228. doi: 10.1200/JCO.2008.16.4244. J Clin Oncol. 2008. PMID: 18445855 No abstract available.
Comment on
-
Phase III study of capecitabine plus oxaliplatin compared with continuous-infusion fluorouracil plus oxaliplatin as first-line therapy in metastatic colorectal cancer: final report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial.J Clin Oncol. 2007 Sep 20;25(27):4224-30. doi: 10.1200/JCO.2006.09.8467. Epub 2007 Jun 4. J Clin Oncol. 2007. PMID: 17548839 Clinical Trial.
-
Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study Group.J Clin Oncol. 2007 Sep 20;25(27):4217-23. doi: 10.1200/JCO.2006.09.2684. Epub 2007 Jun 4. J Clin Oncol. 2007. PMID: 17548840 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
